Latest Machine Learning News

Micro-X's U.S. subsidiary has won a $1.3 million contract extension from the U.S. Department of Homeland Security to push forward its Passenger Self-Screening Checkpoint program, moving closer to real-world airport trials.

Legacy Minerals leverages AI to pinpoint 38 new gold-silver-copper targets at Mt Carrington, advancing exploration beyond its 115Moz silver equivalent resource with imminent drilling at Emu Prospect.

FirstWave Cloud Technology delivered a strong Q3 FY26 with a $1.40m net operating cash inflow and a major two-year licensing agreement with Mexico’s Banobras bank, marking a key milestone in its AI compliance pivot.

Pathkey.AI appoints Andrew Farnsworth as CEO, leveraging his defence and AI expertise to drive commercialisation of TrialKey and Chipforge platforms.

Gentrack is set to acquire Dubai Technology Partners for about US$10 million, enhancing its Veovo platform with AI-driven airport operations technology and deepening its Middle East footprint.

Pointerra Limited delivered a 214% jump in Q3 FY26 customer receipts to A$2.2 million, driven by milestone invoicing and new Tier 1 utility contracts, edging closer to operating cashflow breakeven.

Tambourah Metals has delivered compelling high-grade gold assay results from its Bryah and Tambourah projects, while accelerating exploration of critical minerals at Speewah North with a solid $5.35 million cash buffer.

Tinybeans Group has reported its inaugural EBITDA-positive quarter with US$8K profit, driven by strong subscription growth, e-commerce expansion, and operational efficiencies following the Qeepsake acquisition.

Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

BCAL Diagnostics is expanding access to its Avantect pancreatic and ovarian cancer blood tests across Australia through partnerships with major pathology providers. This move marks a significant step in making early cancer detection more widely available.

Qoria Limited updates shareholders on its proposed merger with Aura Consolidated Group, highlighting Aura's robust financial performance and cost-saving initiatives. The merger remains unanimously recommended by Qoria's board, pending regulatory and shareholder approvals.